Takashi Sakai, MD-Ph.D.

In April 2024, Takashi became a member of the Hata lab. He received his MD from Tsukuba University, Japan, and has been working as a thoracic surgeon. He developed an interest in cancer biology related to thoracic malignancies while working. His research focused on the tumor microenvironment of NSCLC at the National Cancer Center, Japan, and Toho University in Japan, and he finished his PhD at Toho University under the supervision of Akira Iyoda. He is interested in novel effective therapies that can target oncogenic drivers in thoracic malignancies including malignant pleural mesothelioma, and he began researching.